Chris Degnan serves as Executive at Verrica Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Chris Degnan has executed 5 insider transactions totaling $101.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 31, 2026 involved receiving (via award) 32,609 shares valued at $0.
Chris Degnan currently holds 32,609 shares of Verrica Pharmaceuticals Inc. (VRCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chris Degnan has been a net buyer of VRCA stock. They have purchased $64.6K and sold $37.1K worth of shares.
Chris Degnan's most recent insider trade was on Jan 31, 2026, when they sold 32,609 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $16.85 |
| Discretionary |
| Oct 8, 2025 | URGN | $0 | Option Exercise | 4,483 | $N/A | Discretionary |
| Mar 13, 2023 | GRTX | $19.6K | Purchase | 10,000 | $1.96 | Discretionary |
| Jun 19, 2018 | VRCA | $45.0K | Purchase | 3,000 | $15.00 | Discretionary |